Clinical Trial Update: Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer [Phase 1]

View source ↗

Summary

This document reports the completion of the Phase 1 portion of a Phase I/II trial evaluating intratumoral dendritic cell immunotherapy in combination with gemci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Intratumoral dendritic cell immunotherapy

Snippet

Sponsor: George Albert Fisher | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED